Age, Biography and Wiki
Michael J. Reed was born on 30 May, 1944, is a Professor Michael J. Reed was British chemist. Discover Michael J. Reed's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 64 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
64 years old |
| Zodiac Sign |
Gemini |
| Born |
30 May, 1944 |
| Birthday |
30 May |
| Birthplace |
N/A |
| Date of death |
6 April, 2009 |
| Died Place |
N/A |
| Nationality |
|
We recommend you to check the complete list of Famous People born on 30 May.
He is a member of famous Professor with the age 64 years old group.
Michael J. Reed Height, Weight & Measurements
At 64 years old, Michael J. Reed height not available right now. We will update Michael J. Reed's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Michael J. Reed Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Michael J. Reed worth at the age of 64 years old? Michael J. Reed’s income source is mostly from being a successful Professor. He is from . We have estimated Michael J. Reed's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Professor |
Michael J. Reed Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Professor Michael J. Reed (30 May 1944 – 6 April 2009) was a British chemist who held the position of professor of steroid biochemistry at Imperial College, London.
Reed obtained a BSc in zoology from the University of London in 1967 and an MSc in biochemistry from Imperial College in 1969.
He then commenced research into the actions and metabolism of ethinyloestradiol with Ken Fotherby at the Royal Postgraduate Medical School, London, culminating in a PhD in 1973.
He continued to work on the regulation of oestrogen synthesis in endometrial cancer before moving to St Mary's Hospital Medical School in 1976, to join Vivian James in the Department of Chemical Pathology.
He then focused his attention to the regulation of aromatase in breast cancer.
Reed was appointed lecturer at St. Mary's in 1978, senior lecturer in 1983 and reader in 1992.
His principal work was on in vivo methods, using radioactive substrate infusions to calculate the extent of aromatisation in postmenopausal women with breast cancer.
In 1995 he was appointed professor of steroid biochemistry in the Department of Endocrinology and Metabolic Medicine.
After the creation of the Imperial College School of Medicine, Reed's research became more directed towards developing therapies.
Together with A. Purohit, he developed a research programme in steroid sulphatase inhibitors for the control of steroid-responsive cancers.
These studies attracted commercial funding and the creation of an Imperial Start-up – Sterix Ltd, formed in 1998 as a spin-off from Imperial College, London and the University of Bath, based on the work of Reed and Barry V. L. Potter (professor of medicinal chemistry, University of Bath) in the field of steroid hormones.
It resulted the development of inhibitors for several steroidogenic enzyme targets.
One of these completed a Phase 1 trial in women with advanced breast cancer, in collaboration with Charles Coombes and CRUK.
Sterix was acquired by Ipsen in 2004.
Reed won the 2009 GlaxoSmithKline (GSK) International Achievement Award, jointly with Barry Potter.
He also won The Royal Society of Chemistry BMCS Malcolm Campbell Memorial Award 2009, jointly with L.W.L. Woo and B.V.L. Potter from The University of Bath and A. Purohit from Imperial College.
A commemorative symposium was held on 6 April 2010 in Edinburgh to celebrate his scientific achievements.
The symposium focused on the main area of Reed's research – the production and role of female sex hormones in women with hormone-dependent cancers.
